Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2717  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
Read this article

 


    Article Cited by others

DRUG REVIEW

Regadenoson

Bengalorkar G M, Bhuvana K, Sarala N, Kumar T N

Year : 2012| Volume: 58| Issue : 2 | Page no: 140-146

   This article has been cited by
 
1 Adenosine A2A Receptor Activation Enhances Blood–Tumor Barrier Permeability in a Rodent Glioma Model
Amélie Vézina, Monica Manglani, DreeAnna Morris, Brandon Foster, Matthew McCord, Hua Song, Meili Zhang, Dionne Davis, Wei Zhang, Jessica Bills, Kunio Nagashima, Priya Shankarappa, Jessica Kindrick, Stuart Walbridge, Cody J. Peer, William D. Figg, Mark R. Gilbert, Dorian B. McGavern, Leslie L. Muldoon, Sadhana Jackson
Molecular Cancer Research. 2021; 19(12): 2081
[Pubmed]  [Google Scholar] [DOI]
2 Regadenoson Stress Testing: A Comprehensive Review With a Focused Update
Karim O Elkholy, Omar Hegazy, Adeniyi Okunade, Suat Aktas , Temitope Ajibawo
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors
David S. Hong, Patricia LoRusso, Omid Hamid, Filip Janku, Muaiad Kittaneh, Daniel V.T. Catenacci, Emily Chan, Tanios Bekaii-Saab, Shirish M. Gadgeel, Robert D. Loberg, Benny M. Amore, Yuying C. Hwang, Rui Tang, Gataree Ngarmchamnanrith, Eunice L. Kwak
Clinical Cancer Research. 2019; 25(8): 2403
[Pubmed]  [Google Scholar] [DOI]
4 Pharmacology, Part 4: Nuclear Cardiology
Geoffrey M. Currie
Journal of Nuclear Medicine Technology. 2019; 47(2): 97
[Pubmed]  [Google Scholar] [DOI]
5 When to re-dose regadenoson?
Gregory S. Thomas,Aaron F. Jolly,Michael Safani
Journal of Nuclear Cardiology. 2015;
[Pubmed]  [Google Scholar] [DOI]
6 Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma
Carlos Salgado Garcia,Amelia Jimenez Heffernan,Elena Sanchez de Mora,Carlos Ramos Font,Juana Lopez Martin,Francisco Rivera de los Santos,Ignacio Ynfante Milá
European Journal of Nuclear Medicine and Molecular Imaging. 2014; 41(1): 119
[Pubmed]  [Google Scholar] [DOI]
7 Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma
Garcia, C.S., Heffernan, A.J., Sanchez De Mora, E., Rivera De Los Santos, F., Ynfante Milá, I.
European Journal of Nuclear Medicine and Molecular Imaging. 2014; 41(1): 119-125
[Pubmed]  [Google Scholar]
8 Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole
Friedman, M. and Spalding, J. and Kothari, S. and Wu, Y. and Gatt, E. and Boulanger, L.
Journal of Medical Economics. 2013; 16(4): 449-460
[Pubmed]  [Google Scholar]
9 Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole
Michelle Friedman,James Spalding,Smita Kothari,You Wu,Elyse Gatt,Luke Boulanger
Journal of Medical Economics. 2013; 16(4): 449
[Pubmed]  [Google Scholar] [DOI]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow